CoagulationDisorders near Hackensack, NJ

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Care Philosophy: "I am a medical oncologist with an expertise in breast cancer medicine. My focus is the multidisciplinary care and treatment of patients, especially those who have tumors that are high risk. Because I am a passionate advocate of personalized medicine, my goal is to develop new successful treatments that exploit our knowledge of the cancer genome and the immuno cell network for immunotherapy, in order to improve the outcomes of breast cancer patients. To do this, I actively participate in team science and recognize the importance of establishing strong connections with other disciplines involved in the care of patients and who are in the laboratory, as our goals are the same- to cure breast cancer. I view my patients as individuals and welcome open and inclusive communication when discussing treatment strategies as it is paramount they feel comfortable with an established treatment pathway."

Biography: Dr. Farrah Hussain, MD is a Maternal-Fetal Medicine Specialist who practices in New York, NY. She is 37 years old and has been practicing for 11 years. Dr. Farrah Hussain, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Care Philosophy: I am a medical oncologist who specializes in cancers of the lung and thymus. I work closely with our multidisciplinary team of expert thoracic surgeons, radiation oncologists, interventional radiologists, palliative care/pain management specialists, and nutritionists to provide comprehensive care for our patients. I view each patient and their disease as unique and work to manage their treatment accordingly, always keeping their goals in mind. In order to provide new hopes for the future of lung cancer treatment, our division is also involved in clinical research focusing on precsion medicine, immunotherapy, and novel therapeutics as well as laboratory research to better understand this disease.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Reshef trained in Hematology, Oncology and Bone Marrow Transplantation and received a Master of Science degree in Translational Research from the University of Pennsylvania. He joined Columbia University in 2015 as Director of Translational Research for the Blood and Marrow Transplantation program. He is the Clinical Lead for the CAR-T Cell Program at Columbia, a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center.

Biography: Diane George, MD cares for children and adolescents undergoing stem cell transplantation as a treatment for cancer (particularly leukemia and lymphoma), noncancerous blood disorders (like sickle cell anemia), and immunodeficiencies. She specializes in transplantation for patients who don't have a related bone marrow donor, and also takes care of patients undergoing autologous stem cell transplantation for solid tumors. Dr. George was originally attracted to the field of pediatric oncology because she wanted to take on the challenge of fighting pediatric cancer, and stem cell transplantation offers the ultimate cure in select patients. It is a complex medical field, and Dr. George enjoys being able to take care of children with complex medical conditions. Dr. George also conducts clinical research. She is currently evaluating a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow. This approach reduces the risk of graft-versus-host disease (GVHD) - a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach benefits patients who do not have a well-matched family donor, and it could potentially make bone marrow transplantation an option for more patients. Dr. George is also interested in studying how a patient's immune system rebuilds itself after CD34-selected stem cell transplantation. At NewYork-Presbyterian/Morgan Stanley Children's Hospital, every member of a child's healthcare team shares the same compassion and dedication to helping them get well. Dr. George looks forward each day to the camaraderie, intellectual stimulation, and problem-solving she shares with fellow team members. After being in the field for more than 20 years, Dr. George uses the knowledge and experience she has gained to benefit patients and their families.

Biography: Dr. Julie Fasano, MD is a Hematology Specialist who practices in New York, NY. She is 52 years old and has been practicing for 23 years. Dr. Julie Fasano, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Iwamoto is a neuro-oncologist whose previous training includes a neurology residency at NewYork-Presbyterian/Weill Cornell Medical Center and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. For over three years, Dr. Iwamoto was an attending physician and an investigator at the Neuro-oncology Branch, a trans-institute branch of the National Cancer Institute and National Institute of Neurological Disorders and Stroke, in Bethesda, MD. At the intramural NIH, Dr. Iwamoto was a principal investigator in early phase clinical trials for brain tumors and worked with laboratory and computational scientists on several translational projects in brain tumors. Dr. Iwamoto was recruited to Columbia University as the Deputy Director of the Neuro-oncology Division and is actively developing the clinical and translational research components of this program. He is an expert in the diagnosis, management, and treatment of brain and spinal cord tumors as well as neurological complications of cancer.

Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Care Philosophy: I treat each person as a unique individual. I get to know that person and listen to the medical issue(s) that led him/her to see me. I spend time in conversation and examination to gather the information necessary for a diagnosis and treatment. I discuss the management options so that we can jointly select the appropriate treatment. Every question is welcomed. I enjoy learning about each person and sharing the benefit of my expertise. I hold sacred the trust placed in my care.

Biography: Dr. James Lee is an internationally recognized endocrine surgeon who specializes in the care of patients with thyroid, parathyroid, and adrenal disorders. Dr. Lee is the Chief of Endocrine Surgery and the Edwin K. and Anne C. Weisskopf Professor of Surgical Oncology at Columbia University and the Physician Director of the Endocrine Service Line at the NY Presbyterian Hospital. He serves as Co-Director of the multidisciplinary Columbia Thyroid Center, Parathyroid Center, and Adrenal Center. He has been rated as one of the Best Doctors in America and is one of the highest volume endocrine surgeons in the country. Dr. Lee received his medical degree from Columbia University's College of Physicians and Surgeons, completed his residency in General Surgery at Columbia and went on to a fellowship in Endocrine Surgery at the University of California, San Francisco. Dr. Lee is actively involved in the leadership of Endocrine Surgery at the national and international level. He serves on the Executive Council of the American Association of Endocrine Surgeons and Standing Faculty of the international Endocrine Surgery University. He co-created the inaugural Postgraduate Course in Endocrine Surgery at the American College of Surgeons and is a featured lecturer in the biannual Masters of Endocrine Surgery Course. He has authored over 100 articles and book chapters, including the AAES Parathyroidectomy Guidelines which sets the international standard for the care of patients with parathyroid disease. He is also the Co-Editor of Surgical Endocrinopathies and the Founding Figures which details state of the art care for patients with endocrine disorders as well as the rich history of discovery in the field. Dr. Lee has given over 100 invited lectures and visiting professorships at institutions around the world. He has travelled extensively to teach other endocrine surgeons advanced techniques such as minimally invasive thyroid and parathyroid surgery as well as laparoscopic retroperitoneal adrenalectomy. He has mentored dozens of clinical and research fellows over his career, many of whom are now leaders in their own institutions and abroad. Dr. Lee also serves as the Vice Chair of New Media in the Columbia University Department of Surgery and Chair of the ColumbiaDoctors Communications Committee. In this role, he oversees the digital strategy for multiple groups across the medical center with the mission of providing the highest quality education on health and wellness to the global audience.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Rohit K. Jain MD, MPH is an Associate Professor of Medicine at Weill Cornell Medicine and Attending Physician at NewYork-Presbyterian Hospital- Weill Cornell Medical Center. Dr. Jain earned his medical degree at Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, India. He completed Internal Medicine Residency at Johns Hopkins University/Sinai Hospital of Baltimore and Hematology-Oncology Fellowship at Roswell Park Cancer Institute University at Buffalo, New York. After fellowship, Dr. Jain, joined the H. Lee Moffitt Cancer Center in Tampa, Florida as Assistant Professor, and was instrumental in building the bladder cancer program. Dr. Jain was selected as Castle Connolly "Top Doctor" for 2024, as well as one of America's Best Prostate Cancer Oncologist by Newsweek magazine in 2024. Dr. Jain was recruited to Weill Cornell Medicine (WCM) in 2024. He cares for patients with bladder (urothelial), kidney (renal), prostate and testicular cancers, with a major focus in urothelial cancers. His research interests are primarily in urothelial and prostate cancers. Dr. Jain is involved in biomarker research as well as developing innovative clinical trials for patients, and he has received funding from the National Cancer Institute (NCI).

Care Philosophy: I am dedicated to the surgical and medical management of women's cancer and also committed to advancing clinical and translational research in this field, with a focus on cancer genetics.